Alto Neuroscience Wants to Revolutionize Mental Health Treatment

Fresh of its IPO at the NYSE, CEO of Alto Neuroscience Dr. Amit Etkin discusses how the company wants to innovate psychiatric medicine.
More Videos
The Business Of Defense
Step inside the high stakes world of defense contractors and discover who's developing technology for the battlefield of tomorrow.
Load More